JPRN-UMIN000015914已完成未知
Additional research on biomarkers in "Phase II study of cetuximab rechallenge in the third-line therapy in patients with KRAS wild-type metastatic colorectal cancer (JACCRO CC-08) " - JACCRO CC-08AR
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients who are regarded as inadequate for study enrollment by investigators (2) Patients who refuse to supply the section
研究者
相似试验
已完成
不适用
Additional research on biomarkers in "Phase II study of panitumumab rechallenge in the third-line therapy in patients with KRAS wild-type metastatic colorectal cancer (JACCRO CC-09) "Colorectal CancerJPRN-UMIN000015916Japan Clinical Cancer Research Organization35
已完成
不适用
Research on biomarkers in "A randomized phase II study to investigate the deepness of response of FOLFOXIRI plus cetuximab (Erbitux) versus FOLFOXIRI plus bevacizumab as the first-line therapy in metastatic colorectal cancer patients with RAS wild-type tumors"Colorectal cancerJPRN-UMIN000018412Japan Clinical Cancer Research Organization227
招募中
不适用
A biomarker research of "A phase II study of second-line combination therapy with FOLFIRI plus ramucirumab in patients with RAS wild-type unresectable advanced/recurrent colorectal cancer "Colorectal cancerJPRN-UMIN000034885Japan Clinical Cancer Research Organization (JACCRO)80
招募中
不适用
Research for early detection of adverse events of immune checkpoint inhibitorsung cancerJPRN-UMIN000044022Hokkaido University of Science Faculty of Pharmaceutical Sciences25
招募中
不适用
An Additional Analysis of Data from the PARADIGM Exploratory Study in Patients with Advanced/Recurrent Colorectal CancerColorectal cancerJPRN-jRCT1031210293Contact for Clinical Trial Information757